CHOP employees use grants to fund innovative programs in their communities

1 in 6 also filled an opioid prescription two weeks prior to the actual surgery, increasing risk of persistent opioid use

Authors highlight urgent need to tailor health interventions and educate caregivers.

Watch our new videos about H5N1, COVID-19 boosters, and the SARS-CoV-2 lab leak theory. Also, check out our new pneumococcal infographic, updated Q&As, and free newsletters.

The short answer to this question is no, but in some cases, certain racial or ethnic groups are mentioned in vaccine recommendations. Watch the video to see why.

The difficulty of selecting a vaccine strain of virus was on display during the planning for 2024-2025 COVID-19 vaccines. Find out what happened and what it means for this year's updated versions.

The life and legacy of the late Dr. Kwaku Ohene-Frempong was celebrated by family, friends and colleagues at his portrait unveiling ceremony on CHOP’s campus on June 20.

Researchers at Children’s Hospital of Philadelphia (CHOP) and the University of Pennsylvania Perelman School of Medicine pioneered a new model that offers a potential platform for developing novel therapies to treat Alpha Thalassemia (AT), a severe blood disorder. The findings were published in the journal Blood.

Results led to expanded FDA approval in January 2024.

Researchers in the Division of Orthopedics and Sports Medicine and Performance Center at Children’s Hospital of Philadelphia (CHOP) announced results from a large retrospective study of patients surgically treated for Patellar Sleeve Fractures (PSFs), rare knee fractures that occur when a piece of bone and cartilage separates from kneecap. They found that in most pediatric patients with displaced fractures, surgery was effective in restoring full range of motion (ROM) and enabled them to return to their regular activities.